Adverum Biotechnologies
Redwood City, US · Delaware corporation · 1 known investors
Founders & leadership
TW
Thomas W. ChalbergCo-founder
SD
Steven D. SchwartzCo-founder
MS
Mark S. BlumenkranzCo-founder
LR
Linda RubinsteinExecutive
SS
Setareh SeyedkazemiExecutive
KP
Kishor Peter SoparkarExecutive
LF
Laurent FischerExecutive
RG
Rabia Gurses OzdenNamed on SEC filing
SH
Soo HongNamed on SEC filing
JS
James ScopaNamed on SEC filing
ML
Mark LupherNamed on SEC filing
Board
PW
Paul WachterBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$192.9M disclosed across 3 rounds · 2014–2024
▶$127.8MraisedFeb 2024 · 20 investors · BiotechnologyRule 506(b)
▶$127.8MraisedFeb 2024 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- C. David NicholsonDirector
- Linda RubinsteinExecutive Officer
- Rabia Gurses OzdenDirector
- Setareh SeyedkazemiExecutive Officer
- Kishor Peter SoparkarExecutive Officer
- Soo HongDirector
- Dawn SvoronosDirector
- James ScopaDirector
- Reed TucksonDirector
- Mark LupherDirector
- Laurent FischerExecutive Officer, Director
- Patrick MachadoDirector
- Scott WhitcupDirector
- Offering amount
- $127.8M
- Amount sold
- $127.8M
- Sales commissions
- $7.7M
- Placement agents
- Cowen and Company, LLC, Truist Securities, Inc.
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedSep 2014 · 1 investors · BiotechnologyRule 506(b)
▶$10MraisedSep 2014 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Linda BainExecutive Officer
- Paul WachterDirector
- Mehdi GasmiExecutive Officer
- Mark BlumenkranzDirector
- John McLaughlinDirector
- Hans HullExecutive Officer
- Thomas ChalbergExecutive Officer, Director
- Steven SchwartzDirector
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- Aug 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$55.1MraisedApr 2014 · 45 investors · BiotechnologyRule 506(b)
▶$55.1MraisedApr 2014 · 45 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas W. ChalbergExecutive Officer, Director
- John McLaughlinDirector
- Steven D. SchwartzDirector
- Paul WachterDirector
- Mark S. BlumenkranzDirector
- Offering amount
- $56M
- Amount sold
- $55.1M
- Sales commissions
- $2.5M
- Placement agents
- Cowen and Company, LLC
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Adverum Biotechnologies?
- Adverum Biotechnologies was founded by Thomas W. Chalberg, Steven D. Schwartz, Mark S. Blumenkranz.
- Who are Adverum Biotechnologies's investors?
- Adverum Biotechnologies's investors include Frazier Life Sciences.
- How much funding has Adverum Biotechnologies raised?
- Adverum Biotechnologies has disclosed $192.9M raised across 3 rounds.
- Where is Adverum Biotechnologies headquartered?
- Adverum Biotechnologies is headquartered in Redwood City, US.